Clinical Trial

Validation of Fitbit Measurements in Hospitalized General Medicine Patients

Completed
View on ClinicalTrials.gov →
Summary
Patients admitted to the General Internal Medicine ward are sick and in need of monitoring that cannot be provided at home or treatments best administered in hospital. Standard care currently includes vital signs measurements and in some cases ECG. Wearable devices that continuous monitor patients could provided added information to improve the care of inpatients. This could include more monitoring and catching deterioration before it happens. Wearables have been shown to be largely accurate for monitoring heart rate, however it is still necessary to determine if they can reliably measure sleep, activity, and other health metrics. For this, study investigators are evaluating the validity of FitBit Sense 2 (or other FitBit devices) for measurement of sleep, activity, heart rate, respiratory rate, and oxygen saturation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-13.
Status change: Active, Not Recruiting → Completed 2026-06-17
Trial Details
NCT Number NCT07229833
Lead Sponsor University Health Network, Toronto
Conditions GIM Diagnosis, Medicine, Admission to GIM
Enrollment 33 participants
Start Date 2025-06-01
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-22